GLP1R and Parkinson disease: However, liraglutide, another GLP-1R agonist, revealed no neuroprotective effects in the context of moderate or substantial midbrain dopaminergic neuronal loss and associated functional motor deficits in the rat 6-OHDA lesion model of PD [149].